Analysts are tipping three S&P/ASX 200 Index (ASX: XJO) shares to lift to a higher value than their current share prices.
Resmed Inc (ASX: RMD), Vicinity Centres (ASX: VCX), and Scentre Group (ASX: SCG) shares have all just been upgraded by brokers.
Let's take a look at these three ASX 200 shares in more detail.
Image source: Getty Images
Resmed
This ASX 200 healthcare share develops and supplies medical devices to treat sleep and respiratory conditions. The company's revenue lifted 5% in the first quarter of 2023 to $950.3 million.
Citi analysts have placed a buy rating on the Resmed share price with a $37 price target, the Australian reported. This implies an upside of 13% on the current share price.
Resmed shares are up 0.43% at the time of writing today and fetching $32.83. The ASX 200 has also lifted into the green today, up 0.25%.
The Resmed share price has fallen around 1% over the past 12 months.
Vicinity Centres
Vicinity invests and develops property, including shopping malls. In FY22, the ASX 200 share acquired a 50% interest in the Harbour Town premium outlets on the Gold Coast. Vicinity's profit lifted by $1.2 billion in FY22 compared to FY21.
Analysts at Morgan Stanley have raised Vicinity to equal weight with a $2.26 price target, according to the publication. Vicinity shares are rising 0.74% today to $2.055. Morgan Stanley's price target on Vicinity implies an upside of 10% on the current share price.
The Vicinity share price has soared almost 21% in a year.
Scentre Group
Scentre owns premium shopping malls in Australia and New Zealand. The company's sales growth lifted by $3.5 billion in the 9 months to September 2022, compared to the corresponding time frame in 2021.
Scentre Group shares are 0.66% higher today and currently trading at $3.03. Morgan Stanley has lifted its rating on Scentre share price to overweight with a $3.55 price target. This implies an upside of 17% on today's share price.
Scentre shares have slipped 0.5% in the last year.
